Author

Erkut Demirciler

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

Thymic carcinoma (TC) is a rare and aggressive malignancy with limited evidence guiding second-line treatment after prior systemic therapy. We evaluated real-world outcomes of second-line systemic therapy in a multicenter cohort. Adults with unresectable, recurrent, or metastatic TC who received second-lin...

Fatih Kuş, Fatih Atalah, Gökhan Şahin et al. · BMC Cancer · 0 citations

Open access Aug 2026

Clinicopathological features and survival of early-onset colon cancer: a SEER-based analysis of 156,031 curative-intent surgical patients

Aims: To analyze the clinicopathological features and survival outcomes of early-onset colon cancer (EOCC,

F. Özalp, Özge Yetginoğlu, Şerife Sivridemir et al. · Journal of Medicine and Pall... · 0 citations

Open access Sep 2026

Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

Background/Objectives: While perioperative chemotherapy is standard for locally advanced gastric cancer, no baseline blood marker reliably identifies which patients will respond to treatment. In this retrospective study, we compared eleven inflammatory and nutritional indices against pathological response and survival...

Erkut Demirciler, K. Canaslan, H. I. Ellez et al. · Journal of Clinical Medicine · 0 citations